BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2838931)

  • 1. The primary wave of epinephrine-induced platelet aggregation represents alpha 2-adrenoceptor status.
    Mehta J; Mehta P; Krop I; Lawson D
    Thromb Res; 1988 Mar; 49(6):531-7. PubMed ID: 2838931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human platelet alpha 2-adrenoceptors: relationship between radioligand binding studies and adrenaline-induced aggregation in normal individuals.
    Swart SS; Pearson D; Wood JK; Barnett DB
    Eur J Pharmacol; 1984 Aug; 103(1-2):25-32. PubMed ID: 6090177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction between amitraz and alpha 2-adrenoceptors inhibits epinephrine-induced canine platelet aggregation.
    Koeiman NR; Hsu WH
    Arch Int Pharmacodyn Ther; 1991; 310():56-65. PubMed ID: 1663333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic regulation of alpha 2-adrenoceptor number and function in man.
    Jones CR; Hamilton CA; Whyte KF; Elliott HL; Reid JL
    Clin Sci (Lond); 1985; 68 Suppl 10():129s-132s. PubMed ID: 2857608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-Methylated and sulfoconjugated catecholamines: differential activities at human platelet alpha 2-adrenoceptors.
    Lenz T; Werle E; Strobel G; Weicker H
    Can J Physiol Pharmacol; 1991 Jul; 69(7):929-37. PubMed ID: 1683267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p-[125I]iodoclonidine is a partial agonist at the alpha 2-adrenergic receptor.
    Gerhardt MA; Wade SM; Neubig RR
    Mol Pharmacol; 1990 Aug; 38(2):214-21. PubMed ID: 1974694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labelling of human platelet alpha 2-adrenoceptors with the full agonist [3H](-)adrenaline.
    Garcia-Sevilla JA; Fuster MJ
    Eur J Pharmacol; 1986 May; 124(1-2):31-41. PubMed ID: 3013661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
    Brodde OE; Daul A; O'Hara N; Bock KD
    J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in human platelet alpha 2-adrenergic receptor affinity for agonist in unstable angina.
    Mehta J; Mehta P; Ostrowski N
    J Lab Clin Med; 1985 Dec; 106(6):661-6. PubMed ID: 2866219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
    Galitzky J; Senard JM; Lafontan M; Stillings M; Montastruc JL; Berlan M
    Br J Pharmacol; 1990 Aug; 100(4):862-6. PubMed ID: 1976403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of alpha 2-adrenergic receptors of intact and functional washed human platelets by binding of 3H-dihydroergocryptine and 3H-yohimbine--correlation of 3H-yohimbine binding with the potentiation by adrenaline of ADP-induced aggregation.
    Lanza F; Cazenave JP
    Thromb Haemost; 1985 Aug; 54(2):402-8. PubMed ID: 3001964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet alpha 2-adrenoceptors in heroin addicts during withdrawal and after treatment with clonidine.
    Garcia-Sevilla JA; Ugedo L; Ulibarri I; Gutierrez M
    Eur J Pharmacol; 1985 Aug; 114(3):365-74. PubMed ID: 2998814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet hyperaggregability and increased alpha-adrenoceptor density in anorexia nervosa.
    Luck P; Mikhailidis DP; Dashwood MR; Barradas MA; Sever PS; Dandona P; Wakeling A
    J Clin Endocrinol Metab; 1983 Nov; 57(5):911-4. PubMed ID: 6311864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human blood platelet alpha adrenoceptor in view of the effects of various imidazol(in)e drugs on aggregation.
    Petrusewicz J; Kaliszan R
    Gen Pharmacol; 1991; 22(5):819-23. PubMed ID: 1662170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of verapamil with human platelet alpha-adrenergic receptors.
    Barnathan ES; Addonizio VP; Shattil SJ
    Am J Physiol; 1982 Jan; 242(1):H19-23. PubMed ID: 6277203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
    J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivo.
    Galinier M; Senard JM; Valet P; Boneu B; Galinier F; Montastruc JL
    Arch Int Pharmacodyn Ther; 1989; 301():30-9. PubMed ID: 2576196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of phospholipase A2 on human blood platelet alpha adrenergic receptor function.
    Rao GH; White JG
    Thromb Res; 1989 Mar; 53(5):427-34. PubMed ID: 2544037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist binding at alpha 2-adrenoceptors of human platelets using 3H-UK-14,304: regulation by Gpp(NH)p and cations.
    Schloos J; Wellstein A; Palm D
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Jul; 336(1):48-59. PubMed ID: 2888026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.